Brown S, Banfill K, Aznar MC, Whitehurst P, Faivre Finn C (2019) The evolving role of radiotherapy in non-small cell lung cancer. Br J Radiol 92(1104):20190524
Article PubMed PubMed Central Google Scholar
Chen C, Wu Y, Lu HL, Liu K, Qin X (2022) Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation in vivo. PeerJ 10:e13138
Article PubMed PubMed Central Google Scholar
de Almeida AS, Bernardes LB, Trevisan G (2021) TRP channels in cancer pain. Eur J Pharmacol 904:174185
Fan T, Li S, Xiao C, Tian H, Zheng Y, Liu Y, Li C, He J (2022) CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition. Int J Biol Sci 18(11):4275–4288
Article CAS PubMed PubMed Central Google Scholar
Fang C, Dai L, Wang C, Fan C, Yu Y, Yang L, Deng H, Zhou Z (2021) Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1alpha in colorectal cancer. Mol Oncol 15(12):3513–3526
Article CAS PubMed PubMed Central Google Scholar
Gohara K, Okazaki A, Takeda Y, Iwasa K, Shibata K (2021) Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports. Respir Med Case Rep 33:101469
PubMed PubMed Central Google Scholar
Hasako S, Terasaka M, Abe N, Uno T, Ohsawa H, Hashimoto A, Fujita R, Tanaka K, Okayama T, Wadhwa R, Miyadera K, Aoyagi Y, Yonekura K, Matsuo K (2018) TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations. Mol Cancer Ther 17(8):1648–1658
Article CAS PubMed Google Scholar
Ito H, Nakayama H, Yokose T, Nagashima T, Morohoshi T, Tajiri M, Maehara T, Watanabe K, Arai H, Yamamoto T, Woo T, Nishii T, Ishikawa Y, Morita S, Masuda M (2020) A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery. Jpn J Clin Oncol 50(2):198–205
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550–1558
Article CAS PubMed PubMed Central Google Scholar
Jiang H, Li Y, Wang T (2021) Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: a systematic review and network meta-analysis. Cir Esp (engl Ed) 99(6):412–420
Jiang Y, Han D, Zhao Y, Zhang C, Shi X, Gu W (2022) Multi-omics analysis of the prognosis and biological function for TRPV channel family in clear cell renal cell carcinoma. Front Immunol 13:872170
Article CAS PubMed PubMed Central Google Scholar
Ju G, Yao Z, Zhao Y, Zhao X, Liu F (2023) Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. Sci Rep 13(1):10020
Article CAS PubMed PubMed Central Google Scholar
Kang HG, Kim SJ (2022) High Expression of Pregnancy Specific Beta-1-glycoprotein 1 Is Associated With Poor Gastric Cancer Prognosis. In Vivo 36(6):2700–2707
Article CAS PubMed PubMed Central Google Scholar
Kanugula AK, Adapala RK, Jamaiyar A, Lenkey N, Guarino BD, Liedtke W, Yin L, Paruchuri S, Thodeti CK (2021) Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity. Angiogenesis 24(3):647–656
Article CAS PubMed PubMed Central Google Scholar
Kawashima Y, Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Seike M, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M (2022) Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Lancet Respir Med 10(1):72–82
Article CAS PubMed Google Scholar
Khattar V, Wang L, Peng JB (2022) Calcium selective channel TRPV6: Structure, function, and implications in health and disease. Gene 817:146192
Article CAS PubMed PubMed Central Google Scholar
Kim H, Barua A, Huang L, Zhou T, Bolaji M, Zachariah S, Mitra A, Jung SY, He B, Feng Q (2023) The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery. Oncogene 42(22):1821–1831
Article CAS PubMed Google Scholar
Lewis WD, Lilly S, Jones KL (2020) Lymphoma: Diagnosis and Treatment. Am Fam Physician 101(1):34–41
Li G, Luo Q, Wang X, Zeng F, Feng G, Che G (2022a) Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma. Front Endocrinol (lausanne) 13:970269
Li X, Li H, Li Z, Wang T, Yu D, Jin H, Cao Y (2022b) TRPV3 promotes the angiogenesis through HIF-1alpha-VEGF signaling pathway in A549 cells. Acta Histochem 124(8):151955
Article CAS PubMed Google Scholar
Liu G, Pan Y, Li Y, Xu H (2020) lncRNA and mRNA signature for prognosis prediction of glioblastoma. Future Oncol 16(13):837–848
Article CAS PubMed Google Scholar
Liu X, Li J, Wang Q, Bai L, Xing J, Hu X, Li S, Li Q (2022) Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq. Front Immunol 13:1012303
Article CAS PubMed PubMed Central Google Scholar
Luo D, Liao S, Liu Y, Lin Y, Li Y, Liao X (2022) Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis. Pathol Oncol Res 28:1610506
Article CAS PubMed PubMed Central Google Scholar
Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756
Article CAS PubMed PubMed Central Google Scholar
Muller I, Alt P, Rajan S, Schaller L, Geiger F, Dietrich A (2022) Transient Receptor Potential (TRP) Channels in Airway Toxicity and Disease: An Update. Cells 11(18):2907
Article PubMed PubMed Central Google Scholar
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israel-Biet D, Prevot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Riviere F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastre J, Le Borgne-Krams A, Degot T, Launois C, Plantier L, Wemeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H, Investigators E, OrphaLung N (2022) Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 10(1):26–34
Article CAS PubMed Google Scholar
Nie Y, Feng F, Luo W, Sanders AJ, Zhang Y, Liang J, Chen C, Feng W, Gu W, Liao W, Wang W, Chen J, Zhang L, Jiang WG, Li J (2022) Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting. Cancer Gene Ther 29(10):1405–1417
Article CAS PubMed PubMed Central Google Scholar
Rattila S, Kleefeldt F, Ballesteros A, Beltrame JS, Ribeiro ML, Ergün S, Dveksler G (2020) Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells. Reproduction 160(5):737–750
Article CAS PubMed PubMed Central Google Scholar
Reck M, Remon J, Hellmann MD (2022) First-Line Immunotherapy for Non-Small-Cell Lung Cancer. J Clin Oncol 40(6):586–597
Article CAS PubMed Google Scholar
Sasase T, Fatchiyah F, Ohta T (2022) Transient receptor potential vanilloid (TRPV) channels: Basal properties and physiological potential. Gen Physiol Biophys 41(3):165–190
Article CAS PubMed Google Scholar
Shen ML, Xiao A, Yin SJ, Wang P, Lin XQ, Yu CB, He GH (2019) Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis. Gene 706:115–123
Article CAS PubMed Google Scholar
Siveen KS, Prabhu KS, Parray AS, Merhi M, Arredouani A, Chikri M, Uddin S, Dermime S, Mohammad RM, Steinhoff M, Janahi IA, Azizi F (2019) Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation. Sci Rep 9(1):1554
Article PubMed PubMed Central Google Scholar
Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Elstrom R, Huang J, Novotny W, Wei R, Zhu J (2020) Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton’s Tyrosine Kinase. Clin Cancer Res 26(16):4216–4224
Comments (0)